Overview

A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Oral Administration of AJH-2947 in Healthy Korean and/or Caucasian Adult Male Subjects

Status:
Recruiting

Trial end date:
2025-04-01

Target enrollment:

Participant gender:

Summary

Preliminary evaluate of pharmacokinetics, pharmacodynamics, safety and tolerability after oral administration of AJH-2947 in healthy Korean or Caucasian male subjects

Phase:

Phase 1

Details

Lead Sponsor:

JMackem Co., Ltd

Collaborator:

Seoul National University Hospital